Veru - Bathi operasional EBITDA VERU

Logo perusahaan publik verupharma.com (VERU)

Veru Inc. is facing earnings volatility due to a strategic shift toward oncology and regulatory pauses. Revenues are based on the sale of women's health products and the development of cancer therapies. Quarterly EBITDA captures these fluctuations, with the metric currently standing at 0.00. A fully staffed team of specialized experts and scientists is expected to ensure stable growth of indicators in the future.

VERU - Bathi operasional EBITDA Veru ing rentang 23.11.2025 - 10.11.2026

Veru (VERU) - rincian metrik lan laporan keuangan

- kuotasi saiki lan rata-rata prakiraan nilai:
Kutipan saham Veru Corporation|VERU - Target konsensus
- rincian nilai pasar emiten:
Kapitalisasi pasar Veru|VERU - Nilai Total Perusahaan
- indikator nilai buku ekuitas:
Nilai Akuntansi Saham Veru|VERU - Kapitalisasi Buku|Koefisien Nilai Pasar marang Nilai Buku verupharma.com|VERU - Gunggung Aset Perusahaan
- data tingkat utang lan likuiditas finansial:
Utang marang Ekuitas Veru Inc.|VERU - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Veru Inc|VERU - Utang perusahaan|Rasio utang marang aset resik Veru|VERU - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Veru|Rasio jangkoan perantara verupharma.com
- statistik bathi lan rasio pasar:
VERU - Bathi resik|Prakiraan bathi perusahaan Veru Inc.|VERU - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep verupharma.com|VERU - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Veru|VERU - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan Veru|VERU - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan verupharma.com|VERU - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Veru Inc.
Analisis kabeh metrik perusahaan:Veru Corporation
Produk sing diprodhuksi Veru Inc.

This indicator calculates operating cash flow before interest and taxes, eliminating the time gap between quarterly reports to assess the business's actual ability to generate cash. Amid intense competition with pharma behemoths, the organization's overall EBITDA demonstrates the financial resilience of Veru Inc. (VERU) in the face of high oncology drug development risks and the struggle for investment capital.

Analisis pesaing Veru Inc.

ONC - Bathi operasional sadurunge ngurangi amortisasi|HALO: Bathi operasional sadurunge ngurangi amortisasi|RVMD - Bathi operasional EBITDA|Ascentage Pharma (AAPG) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CG Oncology Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|URGN (UroGen) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Bicara Corp BCAX|Bathi operasional sadurunge ngurangi amortisasi PSNL (Personalis, Inc.)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi ERAS (erasca.com)|Bathi operasional EBITDA DCTH (Delcath Systems)|Y-mAbs Therapeutics Inc (YMAB) - Bathi sadurunge bunga, pajak, lan amortisasi|AURA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi CADL (Candel Therapeutics)|ARAY (Accuray Incorporated) - Bathi operasional sadurunge ngurangi amortisasi|SELLAS Life Sciences Group (SLS) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi ACTU|CTOR: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA HURA|Pendapatan operasional sadurunge ngurangi amortisasi Protara Tx|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Fate Therapeutics, Inc. FATE|WHWK: Bathi operasional sadurunge amortisasi|TScan - Bathi operasional EBITDA|Champions Oncology (CSBR) - Bathi operasional sadurunge ngurangi amortisasi|XBIT (xbiotech.com) - Bathi operasional sadurunge ngurangi amortisasi|CVM - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi OSTX|Bathi sadurunge mbayar bunga, pajak, lan amortisasi RADX|Bathi operasional EBITDA ARTV|ANL - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Tempest Tx TPST|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi XLO|RENB: Bathi operasional sadurunge ngurangi amortisasi|MURA - Bathi operasional EBITDA|KAPA: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi OnKure Therapeutics|GDTC (CytoMed Therapeutics Ltd) - Bathi operasional EBITDA|Bathi operasional EBITDA Curis Corp|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Apollomics, Inc. (APLM)|tharimmune.com - Bathi operasional sadurunge amortisasi|Bathi operasional EBITDA ADVB (Advanced Biomed)|GNPX - Bathi operasional sadurunge ngurangi amortisasi|Calidi Bio - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi sunshinebiopharma.com|xeneticbio.com (XBIO) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|salariuspharma.com - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi PPBT|AONC: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA BGNE|Bathi operasional sadurunge ngurangi amortisasi Checkpoint Therapeutics Inc CKPT|Elevation Oncology - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA iCAD Inc. ICAD|IKNA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi NTBL (Notable Labs Ltd)|VIRX: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi MorphoSys Corporation (MOR)|Bathi operasional sadurunge ngurangi amortisasi NAYA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi AAPGV